List of titles

List of titles

You are on page 1 of 3
We found 61 results for your search

Direct communication with healthcare professionals on Pegasys (peginterferone alfa-2a) Highlights News

Pegasys® (peginterferon alfa-2a): supply shortage of 90/135/180 micrograms solution for injection in pre-filled syringes.

Mon Nov 04 00:00:00 CET 2024 Access to medicinal products

Direct communication with healthcare professionals concerning a shortage of the medicinal product NovoSeven (eptacog alfa) Highlights News

Novo Nordisk SpA, in agreement with the European Medicines Agency and the Italian Medicines Agency provides information to healthcare professionals on shortage of the medicine NovoSeven® (eptacog alfa).

Mon Aug 19 00:00:00 CEST 2024 Access to medicinal products

Direct communication with healthcare professionals on CHENPEN® (adrenaline) Highlights News

AIFA provides information to healthcare professionals on the upcoming shortage of the medicine Chenpen.

Mon Jul 08 00:00:00 CEST 2024 Access to medicinal products

Aggiornamento elenco dei medicinali che non possono essere sottratti alla distribuzione e alla vendita Highlights News

L’AIFA, con Determina DTS/99/2024, ha aggiornato l’elenco dei medicinali che non possono essere sottratti alla distribuzione e alla vendita, al fine di garantire una fornitura di farmaci sufficiente a rispondere alle esigenze di cura sull’intero territorio nazionale.

Fri Jun 28 00:00:00 CEST 2024 Access to medicinal products

Chiarimenti sul procedimento di irrogazione di sanzioni amministrative pecuniarie Highlights News

Si rende opportuno richiamare il procedimento seguito dall’AIFA, con specifico riferimento alla fase di contestazione della violazione di norme agli interessati e a quella, successiva ed eventuale, di adozione dell’ordinanza di ingiunzione di pagamento o di archiviazione.

Thu Jun 06 00:00:00 CEST 2024 Companies Section

Information on the availability of Fluorouracil-based medicines Highlights News

AIFA wishes to provide information relating to the availability of Fluorouracil-based medicines on the Italian market.

Thu May 02 00:00:00 CEST 2024 Access to medicinal products

Direct communication with healthcare professionals on Norditropin NordiFlex® (somatropin, hormone of human growth) Highlights News

We hereby inform you that the marketing of the medicinal product Norditropin Nordiflex® 15mg/1.5ml, in all authorized packaging, will be definitively discontinued.

Wed Mar 27 00:00:00 CET 2024 Access to medicinal products

Informazioni sulla carenza del farmaco Nadololo Cheplapharm Highlights News

L’AIFA fornisce informazioni sull’attuale stato di carenza del medicinale Nadololo Cheplapharm 80mg compresse, 30 compresse AIC 041029012.

Tue Mar 19 00:00:00 CET 2024 Access to medicinal products

Gestione carenze di farmaci inseriti nelle liste di trasparenza Highlights News

AIFA riepiloga le modalità distributive applicabili in caso di carenza di farmaci che sono riferimento nelle liste di trasparenza.

Tue Mar 05 00:00:00 CET 2024 Pricing and reimbursement > Transparency Lists

DHCP on Leqvio Highlights News

Leqvio (inclisiran) 284 mg solution for injection in pre-filled syringe: Important information regarding instructions for use before injection.

Wed Dec 20 00:00:00 CET 2023 Quality and Inspections

Direct communication with healthcare professionals on Ozempic (semaglutide) e Victoza (liraglutide)

Ozempic (semaglutide) and Victoza (liraglutide): Supply shortage.

Mon Nov 13 00:00:00 CET 2023 Access to medicinal products

Direct communication with healthcare professionals on Integrilin (eptifibatide)

Cessation of production of Integrilin with immediate effect.

Thu Nov 02 00:00:00 CET 2023 Access to medicinal products

Direct communication with healthcare professionals on Nadololo Cheplapharm Highlights News

The Italian Medicines Agency, in agreement with CHEPLAPHARM Arzneimittel GmbH, would like to give some information on Nadololo Cheplapharm shortage.

Tue Oct 31 00:00:00 CET 2023 Access to medicinal products

Important information on Creon and Creonipe (pancrelipase) shortage

The Italian Medicines Agency, in agreement with the Marketing authorization holder/ dealer Viatris Italia s.r.l., would like to give some information on Creon and Creonipe shortage.

Wed Oct 25 00:00:00 CEST 2023 Access to medicinal products

Direct communication with healthcare professionals on Tresiba Highlights News

Tresiba® FlexTouch® 100 U/ML 5 pre-filled pens (A.I.C. 042658029) is in shortage (discontinous supplies) due to a reduced production capacity of the holder.

Tue Aug 01 00:00:00 CEST 2023 Access to medicinal products

Direct communication with healthcare professionals on Strattera® (atomoxetina) Highlights News

Permanent cessation of the marketing of Strattera® (atomoxetine) hard capsules.

Fri Apr 14 00:00:00 CEST 2023 Access to medicinal products

Direct communication with healthcare professionals on Ozempic® (semaglutide) Highlights News

Ozempic®(semaglutide) solution for injection in pre-filled pen: supply shortage.

Mon Mar 06 00:00:00 CET 2023 Access to medicinal products

Medicine's shortages: official kick-off of CHESSMEN, the Joint Action led by AIFA Highlights News

This project aims at supporting the EU Member States in implementing proper structures, measures and tools to tackle the issue of medicine shortages, strengthening the coordination and harmonisation, monitoring and reporting medicine´s shortages, including a common dataset proposal.

Fri Feb 10 00:00:00 CET 2023 Access to medicinal products

Direct communication with healthcare professionals on Fasturtec (rasburicase) Highlights News

Supply shortage of Fasturtec (rasburicase) 7.5 mg/5 ml powder and solvent for concentrate for solution for infusion (EU/1/00/170/002).

Fri Feb 10 00:00:00 CET 2023 Access to medicinal products

Informazioni sulla carenza del farmaco Frisium Highlights News

L’AIFA desidera fornire informazioni sull’attuale stato di carenza del medicinale FRISIUM 10 mg capsule rigide, 30 capsule (AIC 023451014).

Tue Feb 07 00:00:00 CET 2023 Access to medicinal products

Direct communication with healthcare professionals on Norditropin NordiFlex® (somatropin, hormone of human growth) Highlights News

Recommendation for switching patients treated with Norditropin NordiFlex® (somatropin, hormone of human growth) to alternative medicinal products due to a product shortage.

Mon Feb 06 00:00:00 CET 2023 Access to medicinal products

Direct communication with healthcare professionals on LYMPHOSEEK® (tilmanocept) Highlights News

LYMPHOSEEK® (tilmanocept) 50 micrograms kit for radiopharmaceutical preparation: temporary extension of shelf life.

Tue Jan 31 00:00:00 CET 2023 Access to medicinal products

Direct communication with healthcare professionals on PAZENIR Highlights News

Pazenir® (paclitaxel formulated as albumin bound nanoparticles) 5 mg/ml powder for dispersion for infusion: temporary supply shortage.

Tue Jan 24 00:00:00 CET 2023 Access to medicinal products

Direct communication with healthcare professionals on INSUMAN RAPID (insulin human): temporary supply shortage and marketing cessation Highlights News

Issues at a manufacturing site in the past months resulted in a temporary critical global supply situation affecting the product Insuman Rapid.

Mon Jan 16 00:00:00 CET 2023 Access to medicinal products

Regime transitorio per il rilascio dell’autorizzazione alla distribuzione all’ingrosso di medicinali in territori geograficamente determinati Highlights News

L’intervento del legislatore risponde all’esigenza di contrastare il fenomeno dell’indisponibilità territoriale dei medicinali.

Thu Oct 27 00:00:00 CEST 2022 Access to medicinal products > Medicine shortages

Search filters Expand all Reset filters

  • Type

  • Publication date

  • Category

  • Other filters